LBA16 Primary analysis of efficacy and safety in the CUPISCO trial: A randomised, global study of targeted therapy or cancer immunotherapy guided by comprehensive genomic profiling (CGP) vs platinum-based chemotherapy (CTX) in newly diagnosed, unfavourable cancer of unknown primary (CUP)

Linda Mileshkin, Tilmann Bochtler, Chantal Pauli, Gonzalo Durán-Pacheco, Çağatay Arslan, Frédéric Bigot, Nasséra Chalabi, Natalie Cook, Antoîne Italiano, Ferrán Losa, J. Menezes, Coralie Michaud, Mustafa Özgüroğlu, Roberto Pazo-Cid, Jeffrey S. Ross, K-K. Shiu, Michael Stahl, M. Thomas, Holger Moch, A. Krämer